Equities
Repower reports 2026 H1 EBIT drop amid weaker hydropower output
Swiss utility reports 28% revenue decline in first half, citing low water levels and fading hedging benefits from high-energy prices.
Freshpet CEO Highlights Growth, Margins and Competitive Edge at Barclays Conference
Freshpet Inc. outlined ambitious financial targets, operational efficiencies and market expansion plans amid rising competition in the pet food sector.
AGCO Outlines Growth Roadmap Amid Trough Performance
CEO Eric Hansotia highlights operational targets, cost savings and precision technologies to reach 14%-15% margins by 2029, despite tariff headwinds and regional market slowdowns.
Latham Group CEO: Revenue Growth, Cost Savings and Market Expansion Plans
Latham Group’s CEO Sean Gadd highlighted 10.5% revenue growth and operational efficiencies at Jefferies’ 2026 Industrials Conference, targeting a 35% gross margin by 2026 amid a market slowdown.
VEON Stock Surges to 52-Week High at $69.75
Revenue growth and digital expansion drive the telecom firm’s strong performance, with analysts maintaining a positive outlook.
Cohort PLC Grants Share Options to CEO and Finance Director
The company awards 795 and 509 shares respectively under a 20% discount scheme linked to three-year savings contracts.
CVC Income & Growth resells 1.5m shares from treasury
CVC Income & Growth Limited resold 1.5 million Sterling shares from its treasury at £1.1786 per share on Tuesday to meet ongoing demand. The company's issued share capital and voting rights are updated accordingly.
Greek Banks Benefit from Sector Reforms, J.P. Morgan Forecasts EPS Growth
Inclusion in major European indices and improved fundamentals position Greek banks for 12% annual earnings growth through 2028, despite a 10% discount to peers.
Oracle Reports Fiscal Q1 2027 Earnings: AI Backlog Growth Faces Scrutiny
Oracle’s $638 billion backlog surges 363% YoY, but AI spending bet faces earnings pressure amid capex-heavy guidance and mixed analyst outlooks.
Delaware Court Rules Empery Board Breached Duties in Blocking ATG Capital Nominees
A Delaware judge found Empery Digital's board acted inequitably by rejecting ATG Capital's director slate, clearing the way for a contested election at the Oct. 14 annual meeting.
Canada Goose CEO’s DTR LLC buys 100K shares for ~$1.06M
Dani Reiss’s investment vehicle acquires subordinate voting shares amid broader stake expansion to ~21% of outstanding shares.
Volatus Aerospace wins Canadian military drone contract
Volatus Aerospace has been awarded a contract to provide drones to the Canadian military.
W. P. Carey Announces $1.9B Investment Pipeline for 2026
W. P. Carey Inc. reports a $1.9 billion investment pipeline for 2026, with $1.4 billion already completed year-to-date. The company is actively re-tenating 11 Hellweg stores, aiming for a 100% rent recapture.
Springfield Properties Approves £0.125 Share Buyback Plan with 99.8% Shareholder Approval
Shareholders backed a £1.5 billion buyback programme, allowing up to 11.9 million shares to be repurchased at £0.125 each.
Johnson & Johnson Gets CE Mark for ACUVUE OASYS MAX 2-Week Contact Lens
The company plans a phased rollout in Europe, targeting broader markets in 2027–2028, excluding the U.S.
ZenaTech Raises Stake in Boardwalktecktech to Nearly 20%
AI and drone technology firm acquires over 1.5 million common shares for investment purposes, bringing its ownership to 19.9% on a non-diluted basis.
Prelude Therapeutics receives FDA clearance for Phase 1 breast cancer trial
Prelude Therapeutics (NASDAQ: PRLD) won FDA approval to begin a first‑in‑human Phase 1 study of its oral KAT6A degrader PRT13722 in HR+/HER2‑ breast cancer, with enrollment expected in Q4 2026.
Sage raises €500m with 4.28% 2032 bond
The FTSE 100 firm’s first Euro Medium Term Note Programme issuance lists the notes on London Exchange’s main market
Gresham House Raises Cerillion Stake to 11.31%
London-based asset manager increases holding in software company from 10.35%, crossing disclosure threshold under FCA rules.
Esprinet H1 2026 results show strong sales growth, EBITDA guidance raised
The Italian technology distributor reported H1 2026 gross sales of €2.09 billion, up 8% year‑on‑year, and lifted its full‑year 2026 adjusted EBITDA outlook to €77‑82 million after a 27% rise in H1 EBITDA to €31.9 million.
Copa Holdings Posts 16.8% Traffic Growth in August
Copa Holdings reported that available seat miles and revenue passenger miles each rose 16.8% year-on-year in August, while the load factor held steady at 88.3%.
Artisan Partners Demands Novartis Board Overhaul After Trial Failures
Major shareholder Artisan Partners called for board changes at Novartis after a $12 billion acquisition went to zero and two clinical trials fizzled, wiping nearly $30 billion from market value.
Avicanna outlines pipeline, product-shift momentum at virtual investor forum
Medical-cannabis operator raises revenue to CAD 25 million for 2025 and details a shift toward higher-margin proprietary products and a drug pipeline as it targets profitability.
Schweizer Aktien verlieren vor EZB-Zinsentscheidung: SMI im Minus, Alcon dominiert Verluste
Der Schweizer Leitindex SMI verlor vor der Zinsentscheidung der EZB 0,2 Prozent, während Alcon die größten Verluste verzeichnete. Ölpreise und geopolitische Spannungen im Nahen Osten verstärkten die Vorsicht bei Anlegern.